140 related articles for article (PubMed ID: 15223002)
1. Circadian effects of dopaminergic treatment in restless legs syndrome.
Garcia-Borreguero D; Serrano C; Larrosa O; Granizo JJ
Sleep Med; 2004 Jul; 5(4):413-20. PubMed ID: 15223002
[TBL] [Abstract][Full Text] [Related]
2. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome.
Garcia-Borreguero D; Larrosa O; Granizo JJ; de la Llave Y; Hening WA
Sleep; 2004 Jun; 27(4):669-73. PubMed ID: 15283001
[TBL] [Abstract][Full Text] [Related]
3. Circadian rhythm of restless legs syndrome: relationship with biological markers.
Michaud M; Dumont M; Selmaoui B; Paquet J; Fantini ML; Montplaisir J
Ann Neurol; 2004 Mar; 55(3):372-80. PubMed ID: 14991815
[TBL] [Abstract][Full Text] [Related]
4. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia.
van der Heijden KB; Smits MG; van Someren EJ; Boudewijn Gunning W
J Sleep Res; 2005 Jun; 14(2):187-94. PubMed ID: 15910516
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of dim light melatonin onset testing in diagnosing delayed sleep phase syndrome.
Rahman SA; Kayumov L; Tchmoutina EA; Shapiro CM
Sleep Med; 2009 May; 10(5):549-55. PubMed ID: 18725185
[TBL] [Abstract][Full Text] [Related]
6. Circadian changes in CSF dopaminergic measures in restless legs syndrome.
Earley CJ; Hyland K; Allen RP
Sleep Med; 2006 Apr; 7(3):263-8. PubMed ID: 16564215
[TBL] [Abstract][Full Text] [Related]
7. Validation of the "L-DOPA test" for diagnosis of restless legs syndrome.
Stiasny-Kolster K; Kohnen R; Möller JC; Trenkwalder C; Oertel WH
Mov Disord; 2006 Sep; 21(9):1333-9. PubMed ID: 16705685
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
[TBL] [Abstract][Full Text] [Related]
9. Restless legs syndrome and periodic limb movements.
Vetrugno R; Provini F; Montagna P
Rev Neurol Dis; 2006; 3(2):61-70. PubMed ID: 16820753
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
[TBL] [Abstract][Full Text] [Related]
11. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?
Paulus W; Schomburg ED
Sleep Med Rev; 2006 Jun; 10(3):185-96. PubMed ID: 16762808
[TBL] [Abstract][Full Text] [Related]
12. Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.
Möller JC; Körner Y; Cassel W; Meindorfner C; Krüger HP; Oertel WH; Stiasny-Kolster K
Sleep Med; 2006 Jun; 7(4):333-9. PubMed ID: 16554184
[TBL] [Abstract][Full Text] [Related]
13. Effects of melatonin and bright light administration on motor and sensory symptoms of RLS.
Whittom S; Dumont M; Petit D; Desautels A; Adam B; Lavigne G; Montplaisir J
Sleep Med; 2010 Apr; 11(4):351-5. PubMed ID: 20226733
[TBL] [Abstract][Full Text] [Related]
14. Are modifications of melatonin circadian rhythm in the middle years of life related to habitual patterns of light exposure?
Kawinska A; Dumont M; Selmaoui B; Paquet J; Carrier J
J Biol Rhythms; 2005 Oct; 20(5):451-60. PubMed ID: 16267384
[TBL] [Abstract][Full Text] [Related]
15. [Restless-legs syndrome].
Karroum E; Konofal E; Arnulf I
Rev Neurol (Paris); 2008; 164(8-9):701-21. PubMed ID: 18656214
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome.
García-Borreguero D; Kohnen R; Högl B; Ferini-Strambi L; Hadjigeorgiou GM; Hornyak M; de Weerd AW; Happe S; Stiasny-Kolster K; Gschliesser V; Egatz R; Cabrero B; Frauscher B; Trenkwalder C; Hening WA; Allen RP
Sleep Med; 2007 Aug; 8(5):455-63. PubMed ID: 17543579
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic augmentation of restless legs syndrome.
García-Borreguero D; Williams AM
Sleep Med Rev; 2010 Oct; 14(5):339-46. PubMed ID: 20219397
[TBL] [Abstract][Full Text] [Related]
18. Night-to-night variability in periodic leg movements in patients with restless legs syndrome.
Sforza E; Haba-Rubio J
Sleep Med; 2005 May; 6(3):259-67. PubMed ID: 15854857
[TBL] [Abstract][Full Text] [Related]
19. Dim light melatonin onset (DLMO): a tool for the analysis of circadian phase in human sleep and chronobiological disorders.
Pandi-Perumal SR; Smits M; Spence W; Srinivasan V; Cardinali DP; Lowe AD; Kayumov L
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):1-11. PubMed ID: 16884842
[TBL] [Abstract][Full Text] [Related]
20. Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome.
Benes H
Sleep Med; 2006 Jan; 7(1):31-5. PubMed ID: 16194624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
